The association between expressions of Ras and CD68 in the angiogenesis of breast cancers

Cancer Cell International

Volumn 15, Issue 1, 2015, Pages

  Li, Wei ^a   Liang, Rong Rui ^a   Zhou, Chong ^b   Wu, Meng Yao ^a   Lian, Lian ^a,c   Yuan, Gao Feng ^a,d   Wang, Ming Yun ^a,e   Xie, Xin ^a,f   Shou, Liu Mei ^a,g   Gong, Fei Ran ^a   Chen, Kai ^a   Duan, Wei Ming ^a   Tao, Min ^a,h  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b XUZHOU CENTRAL HOSPITAL   (China)

^c Suzhou Xiangcheng People's Hospital   (China)

^d Sihong People's Hospital Department of Oncology   (China)

^e Gaochun Hospital of Nanjing   (China)

^f XUZHOU MEDICAL UNIVERSITY   (China)

^g ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^h Institute of Clinical Immunology of Jiangsu Province   (China)

Author keywords

Angiogenesis; Breast cancer; CD34; Ras; TAM

Indexed keywords

CD34 ANTIGEN; CD68 ANTIGEN; COLONY STIMULATING FACTOR 1;

ADULT; AGED; ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; CAPILLARY DENSITY; CELL INFILTRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MACROPHAGE; MAJOR CLINICAL STUDY; MIDDLE AGED; MONOCYTE; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; OVERALL SURVIVAL; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR VASCULARIZATION; TUMOR VOLUME; UPREGULATION;

EID: 84924251147     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/s12935-015-0169-1     Document Type: Article

References (29)

1. Tao M, Ma D, Li Y, Zhou C, Zhang Y, Duan W, et al. Clinical significance of circulating tumor cells in breast cancer patients. Breast Cancer Res Treat. 2011;129(1):247-54.
2. Lian L, Li W, Li ZY, Mao YX, Zhang YT, Zhao YM, et al. Inhibition of MCF-7 breast cancer cell-induced platelet aggregation using a combination of antiplatelet drugs. Oncol Letters. 2013;5(2):675-80.
3. Shou LM, Zhang QY, Li W, Xie X, Chen K, Lian L, et al. Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of alpha2 integrin. Oncol Rep. 2013;30(3):1059-66.
4. Chen K, Shou LM, Lin F, Duan WM, Wu MY, Xie X, et al. Artesunate induces G2/M cell cycle arrest through autophagy induction in breast cancer cells. Anti-Cancer Drugs. 2014;25(6):652-62.
5. Jimenez B, Volpert OV. Mechanistic insights on the inhibition of tumor angiogenesis. J Mol Med (Berl). 2001;78(12):663-72.
6. Bottini A, Berruti A, Bersiga A, Brizzi MP, Allevi G, Bolsi G, et al. Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer. Clin Cancer Res Off J Am Assoc Cancer Res. 2002;8(6):1816-21.
7. Fox SB, Harris AL. Histological quantitation of tumour angiogenesis. APMIS Acta Pathologica Microbiologica, et Immunologica Scandinavica. 2004;112(7-8):413-30.
8. Uzzan B, Nicolas P, Cucherat M, Perret GY. Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res. 2004;64(9):2941-55.
9. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 1991;324(1):1-8.
10. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst. 1992;84(24):1875-87.
11. Wu Y, Zhou BP. Inflammation: a driving force speeds cancer metastasis. Cell Cycle. 2009;8(20):3267-73.
12. Coffelt SB, Hughes R, Lewis CE. Tumor-associated macrophages: effectors of angiogenesis and tumor progression. Biochim Biophys Acta. 2009;1796(1):11-8.
13. Ho QT, Kuo CJ. Vascular endothelial growth factor: biology and therapeutic applications. Int J Biochem Cell Biol. 2007;39(7-8):1349-57.
14. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer. 2003;3(1):11-22.
15. Ji H, Houghton AM, Mariani TJ, Perera S, Kim CB, Padera R, et al. K-ras activation generates an inflammatory response in lung tumors. Oncogene. 2006;25(14):2105-12.
16. Schmidt S, Gericke B, Fracasso G, Ramarli D, Colombatti M, Naim HY. Discriminatory role of detergent-resistant membranes in the dimerization and endocytosis of prostate-specific membrane antigen. PLoS One. 2013;8(6):e66193.
17. Colombatti M, Grasso S, Porzia A, Fracasso G, Scupoli MT, Cingarlini S, et al. The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumour cells by activating the MAPK pathways. PLoS One. 2009;4(2):e4608.
18. Sunaga N, Imai H, Shimizu K, Shames DS, Kakegawa S, Girard L, et al. Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer. Int J Cancer J Int du Cancer. 2012;130(8):1733-44.
19. Sobin LH, Fleming ID. TNM classification of malignant tumors, fifth edition (1997). union internationale contre le cancer and the american joint committee on cancer. Cancer. 1997;80(9):1803-4.
20. Carlson RW, McCormick B. Update: NCCN breast cancer clinical practice guidelines. J National Comprehensive Cancer Network: JNCCN. 2005;3 Suppl 1:S7-11.
21. Kim DW, Min HS, Lee KH, Kim YJ, Oh DY, Jeon YK, et al. High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer. Br J Cancer. 2008;98(6):1118-24.
22. Ancrile BB, O'Hayer KM, Counter CM. Oncogenic ras-induced expression of cytokines: a new target of anti-cancer therapeutics. Mol Interv. 2008;8(1):22-7.
23. Ozer E, Sis B, Ozen E, Sakizli M, Canda T, Sarioglu S. BRCA1, C-erbB-2, and H-ras gene expressions in young women with breast cancer. An immunohistochemical study. Appl Immunohistochemistry Molecular Morphol AIMM/Off Publ Soc Appl Immunohistochemistry. 2000;8(1):12-8.
24. Mantovani A, Marchesi F, Porta C, Sica A, Allavena P. Inflammation and cancer: breast cancer as a prototype. Breast. 2007;16 Suppl 2:S27-33.
25. Viacava P, Naccarato AG, Bocci G, Fanelli G, Aretini P, Lonobile A, et al. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast. J Pathol. 2004;204(2):140-6.
26. Cao Y, Paner GP, Kahn LB, Rajan PB. Noninvasive carcinoma of the breast: angiogenesis and cell proliferation. Archives Pathol Laboratory Med. 2004;128(8):893-6.
27. Dhakal HP, Bassarova A, Naume B, Synnestvedt M, Borgen E, Kaaresen R, et al. Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count. Histol Histopathol. 2009;24(8):1049-59.
28. Tang Y, Kim M, Carrasco D, Kung AL, Chin L, Weissleder R. In vivo assessment of RAS-dependent maintenance of tumor angiogenesis by real-time magnetic resonance imaging. Cancer Res. 2005;65(18):8324-30.
29. Rak J, Mitsuhashi Y, Sheehan C, Tamir A, Viloria-Petit A, Filmus J, et al. Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts. Cancer Res. 2000;60(2):490-8.